Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Nutt

Showing results (11-20 of 351) with videos related to

Pageof 36
Sort By:
Clinical Neuropharmacology|January 1, 1992
Pharmacoendocrine studies in anxietyD J Nutt
The Journal of Clinical Psychiatry|August 14, 1999
Care of depressed patients with anxiety symptomsD J Nutt
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Smaller fleas ad infinitum: pharmacological subtypes of anxiety?: The Psychopharmacology of Panic Disorder. November 2nd 1990--Royal Society, LondonD J Nutt
Lancet (London, England)|January 6, 1996
Addiction: brain mechanisms and their treatment implicationsD J Nutt
Journal of Psychopharmacology (Oxford, England)|May 13, 2009
Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?D J Nutt
Journal of Psychopharmacology (Oxford, England)|January 23, 2009
Equasy-- an overlooked addiction with implications for the current debate on drug harmsD J Nutt
British Journal of Clinical Pharmacology|July 1, 1987
Platelet alpha 2-adrenoceptor binding does not predict brain alpha 2-adrenoceptor functionD J Nutt
Depression and Anxiety|May 23, 1998
Efficacy of mirtazapine in clinically relevant subgroups of depressed patientsD J Nutt
The Journal of Pharmacy and Pharmacology|April 1, 1993
The approach to new anxiolyticsD J Nutt
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
EditorialD J Nutt
Pageof 36

Showing results (11-20 of 351) with videos related to

Sort By:
Pageof 36
Clinical Neuropharmacology|January 1, 1992
Pharmacoendocrine studies in anxietyD J Nutt
The Journal of Clinical Psychiatry|August 14, 1999
Care of depressed patients with anxiety symptomsD J Nutt
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Smaller fleas ad infinitum: pharmacological subtypes of anxiety?: The Psychopharmacology of Panic Disorder. November 2nd 1990--Royal Society, LondonD J Nutt
Lancet (London, England)|January 6, 1996
Addiction: brain mechanisms and their treatment implicationsD J Nutt
Journal of Psychopharmacology (Oxford, England)|May 13, 2009
Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?D J Nutt
Journal of Psychopharmacology (Oxford, England)|January 23, 2009
Equasy-- an overlooked addiction with implications for the current debate on drug harmsD J Nutt
British Journal of Clinical Pharmacology|July 1, 1987
Platelet alpha 2-adrenoceptor binding does not predict brain alpha 2-adrenoceptor functionD J Nutt
Depression and Anxiety|May 23, 1998
Efficacy of mirtazapine in clinically relevant subgroups of depressed patientsD J Nutt
The Journal of Pharmacy and Pharmacology|April 1, 1993
The approach to new anxiolyticsD J Nutt
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
EditorialD J Nutt
Pageof 36